Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trial

Andre C. Kalil, Justin Stebbing

Research output: Contribution to journalComment/debatepeer-review

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)1349-1351
Number of pages3
JournalThe Lancet Respiratory Medicine
Volume9
Issue number12
DOIs
StatePublished - Dec 2021

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this